Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New hope for kids with kidney disease: rituximab cuts relapses

NCT ID NCT07049172

First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 29 times

Summary

This study looked at whether the drug rituximab, combined with special nursing care, can reduce relapses in children with a kidney condition called nephrotic syndrome that keeps coming back. 91 children were split into two groups: one got rituximab plus nursing care, the other got a different drug (tacrolimus) plus nursing care. The main goals were to see how well each treatment worked and how often the disease returned over 6 months.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NEPHROTIC SYNDROME IN CHILDREN are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Wuhan Children's Hospital

    Wuhan, Hubei, 430015, China

Conditions

Explore the condition pages connected to this study.